Zosurabalpin: New Antibiotic Targeting Drug-Resistant Superbug

Zosurabalpin, a new antibiotic, shows promise in fighting a drug-resistant superbug and is entering the final phase of human testing. It targets Acinetobacter baumannii, a critical pathogen. The drug works differently from existing antibiotics and may lead to the development of new treatments to combat antibiotic resistance.